Fuzhen Wang, Zhijie An, Lance Rodewald, Dan Wu, Lin Tang, Hui Zheng, Qianqian Liu, George F. Gao, Zundong Yin. Guangdong’s Study of the Effectiveness of China’s Inactivated Vaccines Against the SARS-CoV-2 B.1.617.2 (Delta) VariantJ. China CDC Weekly, 2021, 3(34): 728-730. DOI: 10.46234/ccdcw2021.179
|
Citation:
|
Fuzhen Wang, Zhijie An, Lance Rodewald, Dan Wu, Lin Tang, Hui Zheng, Qianqian Liu, George F. Gao, Zundong Yin. Guangdong’s Study of the Effectiveness of China’s Inactivated Vaccines Against the SARS-CoV-2 B.1.617.2 (Delta) VariantJ. China CDC Weekly, 2021, 3(34): 728-730. DOI: 10.46234/ccdcw2021.179
|
Fuzhen Wang, Zhijie An, Lance Rodewald, Dan Wu, Lin Tang, Hui Zheng, Qianqian Liu, George F. Gao, Zundong Yin. Guangdong’s Study of the Effectiveness of China’s Inactivated Vaccines Against the SARS-CoV-2 B.1.617.2 (Delta) VariantJ. China CDC Weekly, 2021, 3(34): 728-730. DOI: 10.46234/ccdcw2021.179
|
Citation:
|
Fuzhen Wang, Zhijie An, Lance Rodewald, Dan Wu, Lin Tang, Hui Zheng, Qianqian Liu, George F. Gao, Zundong Yin. Guangdong’s Study of the Effectiveness of China’s Inactivated Vaccines Against the SARS-CoV-2 B.1.617.2 (Delta) VariantJ. China CDC Weekly, 2021, 3(34): 728-730. DOI: 10.46234/ccdcw2021.179
|
DownLoad: